Pfizer Announces FDA Acceptance for Review of NDA for ALO-02 By: Benzinga via Benzinga February 13, 2015 at 10:28 AM EST Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug ... Read More >> Related Stocks: Pfizer